The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience

Abstract

A small proportion of FM reports identified actionable mutations and led to direct treatment change. FM testing is expensive and a few of the identified mutations are now part of routine on-site testing. NGS testing is likely to become more widespread, but this research suggests that its true clinical impact may be restricted to a minority of patients.